Amwell Sees FY23 Adj. EBITDA $(162)M-$(167)M
Portfolio Pulse from Benzinga Newsdesk
Amwell has projected its FY23 adjusted EBITDA to be between $(162)M and $(167)M.
November 01, 2023 | 9:56 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Amwell's FY23 adjusted EBITDA is expected to be negative, indicating a potential loss.
Amwell's projected negative EBITDA for FY23 indicates that the company is not expected to generate positive earnings before interest, taxes, depreciation, and amortization. This could be a sign of financial distress, which may negatively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100